Page last updated: 2024-11-03

ono 1078 and Ischemia

ono 1078 has been researched along with Ischemia in 2 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, SH1
Yuan, YM1
Peng, F1
Li, CT1
Zhang, LH1
Lu, YB1
Zhang, WP1
Wei, EQ1
Nakamori, Y1
Komatsu, Y1
Kotani, T1
Kojima, S1
Takeuchi, K1

Other Studies

2 other studies available for ono 1078 and Ischemia

ArticleYear
Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species production and nuclear factor-kappaB activation.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:1

    Topics: Arachidonate 5-Lipoxygenase; Cell Line; Cell Nucleus; Cell Survival; Chromones; Endothelial Cells; G

2009
Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Chromones; Gastric Ac

2010